Clinical Trial Update: Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery

View source ↗

Summary

A clinical trial assessing the EnLight and LightPath imaging systems for gastrointestinal tumor surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Duodenal Cancer
• Gastric Cancer
• Pancreatic Cancer

Drugs mentioned

• EnLight Imaging System
• LightPath Imaging System

Snippet

Sponsor: Lightpoint Medical Limited | Conditions: Gastric Cancer, Pancreatic Cancer | Status: WITHDRAWN